Abbott (NYSE: ABT) reported Q3 EPS of $1.15, $0.20 better than the analyst estimate of $0.95. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $9.63 billion.

GUIDANCE:

Abbott sees FY2022 EPS of $5.17-$5.23, versus the consensus of $5.05.

For earnings history and earnings-related data on Abbott (ABT) click here.